Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bartolozzi, C.
Right arrow Articles by Conte, P. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bartolozzi, C.
Right arrow Articles by Conte, P. F.

Radiology, Vol 197, 812-818, Copyright © 1995 by Radiological Society of North America


ARTICLES

Treatment of large HCC: transcatheter arterial chemoembolization combined with percutaneous ethanol injection versus repeated transcatheter arterial chemoembolization

C Bartolozzi, R Lencioni, D Caramella, C Vignali, R Cioni, S Mazzeo, M Carrai, G Maltinti, A Capria and PF Conte
Department of Radiology, Santa Chiara University Hospital, Pisa, Italy.

PURPOSE: To compare the efficacy of transcatheter arterial chemoembolization (TACE) combined with percutaneous ethanol injection (PEI) versus repeated TACE in the treatment of large hepatocellular carcinoma (HCC). MATERIALS AND METHODS: Fifty-three patients with cirrhosis and a large HCC (main tumor, 3.1-8.0 cm in diameter with no more than two daughter nodules) were enrolled in a prospective, randomized study. Twenty-six patients underwent a single TACE session followed by PEI (TACE-PEI group), whereas 27 patients underwent two to five TACE sessions (TACE group). Both groups of patients were similar with regard to liver function. Follow-up ranged from 8 to 39 months. RESULTS: Complete therapeutic responses were higher (P < .05) and tumor recurrences during follow-up were lower (P < .05) in the TACE-PEI group than in the TACE group. Patients in the TACE-PEI group survived longer than those in the TACE group, although the difference was not significant (P > .1). The rates of survival without recurrence were better in the TACE-PEI group than in the TACE group (P < .05). CONCLUSION: Use of a single TACE session combined with PEI is more effective than repeated TACE in the treatment of large HCC.


This article has been cited by other articles:


Home page
RadiologyHome page
A. Maataoui, J. Qian, M. G. Mack, M. F. Khan, E. Oppermann, M. Roozru, S. Schmidt, W. O. Bechstein, and T. J. Vogl
Liver Metastases in Rats: Chemoembolization Combined with Interstitial Laser Ablation for Treatment
Radiology, November 1, 2005; 237(2): 479 - 484.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
T.-I. Huo, Y.-H. Huang, J.-C. Wu, J.-H. Chiang, P.-C. Lee, F.-Y. Chang, and S.-D. Lee
Sequential transarterial chemoembolization and percutaneous acetic acid injection therapy versus repeated percutaneous acetic acid injection for unresectable hepatocellular carcinoma: a prospective study
Ann. Onc., November 1, 2003; 14(11): 1648 - 1653.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
T. J. Vogl, M. G. Mack, J. O. Balzer, K. Engelmann, R. Straub, K. Eichler, D. Woitaschek, and S. Zangos
Liver Metastases: Neoadjuvant Downsizing with Transarterial Chemoembolization before Laser-Induced Thermotherapy
Radiology, November 1, 2003; 229(2): 457 - 464.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
K. Stuart
Chemoembolization in the Management of Liver Tumors
Oncologist, October 1, 2003; 8(5): 425 - 437.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
S D Ryder
Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults
Gut, May 1, 2003; 52(90003): iii1 - 8.
[Full Text] [PDF]


Home page
RadiologyHome page
C. Camma, F. Schepis, A. Orlando, M. Albanese, L. Shahied, F. Trevisani, P. Andreone, A. Craxi, and M. Cottone
Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: Meta-Analysis of Randomized Controlled Trials
Radiology, July 1, 2002; 224(1): 47 - 54.
[Abstract] [Full Text]


Home page
RadiologyHome page
C. M. Pacella, G. Bizzarri, P. Cecconi, B. Caspani, F. Magnolfi, A. Bianchini, V. Anelli, S. Pacella, and Z. Rossi
Hepatocellular Carcinoma: Long-term Results of Combined Treatment with Laser Thermal Ablation and Transcatheter Arterial Chemoembolization
Radiology, June 1, 2001; 219(3): 669 - 678.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
E. Caturelli, D. A. Siena, S. Fusilli, M. R. Villani, G. Schiavone, M. Nardella, S. Balzano, and F. Florio
Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma in Patients with Cirrhosis: Evaluation of Damage to Nontumorous Liver Tissue-Long-term Prospective Study
Radiology, April 1, 2000; 215(1): 123 - 128.
[Abstract] [Full Text]


Home page
RadiologyHome page
C. B. Winston, L. H. Schwartz, Y. Fong, L. H. Blumgart, and D. M. Panicek
Hepatocellular Carcinoma: MR Imaging Findings in Cirrhotic Livers and Noncirrhotic Livers
Radiology, January 1, 1999; 210(1): 75 - 79.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 1995 by the Radiological Society of North America.